Quest Diagnostics (BSP:Q1UE34) Change In Payables And Accrued Expense : R$148 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Quest Diagnostics Change In Payables And Accrued Expense?

Quest Diagnostics's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was R$-548 Mil. It means Quest Diagnostics's Accounts Payable & Accrued Expense declined by R$548 Mil from Dec. 2023 to Mar. 2024 .

Quest Diagnostics's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was R$-279 Mil. It means Quest Diagnostics's Accounts Payable & Accrued Expense declined by R$279 Mil from Dec. 2022 to Dec. 2023 .

Quest Diagnostics Change In Payables And Accrued Expense Historical Data

The historical data trend for Quest Diagnostics's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Diagnostics Change In Payables And Accrued Expense Chart

Quest Diagnostics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

418.66

2,438.59

84.82

-944.17

-279.29

Quest Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-1,041.72	237.83	-395.10	852.57	-547.78

Quest Diagnostics Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$148 Mil.

Quest Diagnostics Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Quest Diagnostics (BSP:Q1UE34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (BSP:Q1UE34) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

DGX:USA QDI:Germany

Address

500 Plaza Drive, Secaucus, NJ, USA, 07094

Website

https://www.questdiagnostics.com

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (BSP:Q1UE34) Headlines

No Headlines